161 related articles for article (PubMed ID: 34765262)
1. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.
Qin Z; Du Y; Zhou Q; Lu X; Luo L; Zhang Z; Guo N; Ge L
Cardiol Res Pract; 2021; 2021():9943668. PubMed ID: 34765262
[TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Fang C; Chen Z; Zhang J; Jin X; Yang M
Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
[TBL] [Abstract][Full Text] [Related]
3. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
5. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.
Gong X; Zhang T; Feng S; Song D; Chen Y; Yao T; Han P; Liu Y; Li C; Song Z; Gao J; Cui Z; Ma J; Liu Y
Ann Palliat Med; 2021 May; 10(5):5231-5243. PubMed ID: 34044561
[TBL] [Abstract][Full Text] [Related]
6. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
[TBL] [Abstract][Full Text] [Related]
7. Biomarker for the Prediction of Major Adverse Cardiac Events in Patients with Non-ST-Segment Elevation Myocardial Infarction.
Shon HS; Bae JW; Kim KO; Cha EJ; Kim KA
Osong Public Health Res Perspect; 2017 Aug; 8(4):237-246. PubMed ID: 28904845
[TBL] [Abstract][Full Text] [Related]
8. Different treatment interventions affect plasma NT-ProBNP levels and early exercise tolerance in patients with acute ST-segment elevation myocardial infarction.
Wu XL; Zhu R; Jiang H; Li B
Postgrad Med; 2012 Mar; 124(2):58-63. PubMed ID: 22437216
[TBL] [Abstract][Full Text] [Related]
9. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
[TBL] [Abstract][Full Text] [Related]
10. Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention.
Fabris E; Ottervanger JP; Hermanides RS; Ten Berg JM; Sinagra G; Koopmans PC; Giannitsis E; Hamm C; van 't Hof AWJ
Catheter Cardiovasc Interv; 2019 Apr; 93(5):E293-E297. PubMed ID: 30585388
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Fragmented QRS and NT-proBNP in Patients with ST Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
Zhao Q; Zhang R; Hou J; Yu B
Acta Cardiol Sin; 2018 Jan; 34(1):13-22. PubMed ID: 29375220
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP Level Predicts Extent of Myonecrosis and Clinical Adverse Outcomes in Patients with ST-Elevation Myocardial Infarction: A Pilot Study.
Mathbout M; Asfour A; Leung S; Lolay G; Idris A; Abdel-Latif A; Ziada KM
Med Res Arch; 2020 Feb; 8(2):. PubMed ID: 33094161
[TBL] [Abstract][Full Text] [Related]
14. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Admission Peak NT-proBNP Combined with Culprit Plaque Types for Predicting Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study.
Li J; Chen R; Zhou J; Wang Y; Zhao X; Liu C; Zhou P; Chen Y; Song L; Yan S; Yan H; Zhao H
J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547463
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serial N-terminal pro-B-type natriuretic peptide levels in patients with acute myocardial infarction: A prospective study.
Li N; Chen R; Li J; Zhao X; Wang Y; Zhou J; Zhou P; Liu C; Chen Y; Song L; Yan S; Zhao H; Yan H
Am Heart J; 2023 Aug; 262():90-99. PubMed ID: 37116605
[TBL] [Abstract][Full Text] [Related]
17. The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.
He WF; Jiang L; Chen YY; Liu YH; Chen PY; Duan CY; Zeng LH; Fan HL; Wei XB; Guo W; Chen W; Li J; Li WS; Guo ZQ; Liu ZK; Tan N; Chen JY; He PC
BMC Cardiovasc Disord; 2021 Apr; 21(1):202. PubMed ID: 33882836
[TBL] [Abstract][Full Text] [Related]
18. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of N-terminal-pro-brain natriuretic peptide measurements in patients with acute coronary syndromes.
Ranjith N; Pegoraro RJ; Naidoo DP; Esterhuizen TM
Cardiovasc J S Afr; 2006; 17(2):60-6. PubMed ID: 16733598
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide is a biomarker of congestive heart failure and predictive of 30-day untoward clinical outcomes in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Wu CJ; Chang HW; Hung WC; Yang CH; Chen YH; Su CY; Yip HK
Circ J; 2006 Feb; 70(2):163-8. PubMed ID: 16434809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
